Healtheuniverse Inc. (PINKSHEETS: HLUN), a diversified biotechnology development firm specializing in the development and commercialization of patented biopharmaceutical and biomedical products announced today that it is completing its infrastructure development in Singapore with operations expected to begin in September 2006. Corporate headquarters for Asian operations and the research development laboratories for its proprietary stem cell based applications will be housed in Biopolis, Singapore. The wholly owned subsidiary will collaborate with other research and development facilities in Asia in preparation for clinical trials. The planned expansion is a key step in the Company's move to be the first to commercialize the use of stem cell based applications and regenerative medicine in the $15 billion worldwide plastic, reconstructive and cosmetic surgery market.
